Skip to main content

Animations

Funded Studies

The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.

Search or browse funded studies

Previously funded studies appear chronologically, with the most recent appearing first.

Filters
From
To
  • ${value}

Filter Results (2361${count})

  • Therapeutic Pipeline Program, 2020
    Adaptive Deep Brain Stimulation for Gait Retraining in Parkinson's Disease

    Study Rationale:
    Walking impairment in people with Parkinson’s disease (PD) often arises from difficulties in coordinating leg movements in response to environment changes. Continuous stimulation of...

  • Alpha-Synuclein Imaging, 2020
    PET Imaging Probe Development for Alpha-synuclein
    Ken Griffin Alpha-synuclein Imaging Competition Logo

    Study Rationale:
    Alpha-synuclein is a protein that can clump to form Lewy bodies and lewy neurites, which are a hallmark of Parkinson's disease. Being able to identify these clumps in living patients...

  • Therapeutic Pipeline Program, 2020
    Pre-clinical Development of Compounds that Modulate Mitophagy through Regulation of the Mitochondrial GTPase Miro1

    Study Rationale:
    Evidence indicates that mitochondrial dysfunction is a significant contributor to Parkinson’s disease, with the majority of patients exhibiting a shared defect in the processing of...

  • Alpha-Synuclein Imaging, 2020
    Alpha-Synuclein PET Tracer Discovery
    Ken Griffin Alpha-synuclein Imaging Competition Logo

    Study Rationale:
    The discovery of new treatments for Parkinson’s disease has been slowed by the time it takes to answer the question “did a drug work” in a clinical trial. Tests that can assess...

  • Therapeutic Pipeline Program, 2020
    Pregnenolone for the Treatment of L-DOPA-induced Dyskinesia in Parkinson's disease

    Study Rationale:
    Neurosteroids are substances that occur naturally in the brain and help regulate and modulate the activity of brain cells. In previous studies, the investigators demonstrated that...

  • Access to Data and Biospecimens, 2020
    Development of a Biomarker Platform for Parkinson’s Disease Using Patient-derived Cells

    Study Rationale:
    Inadequate understanding of how Parkinson's disease develops is a major roadblock in developing effective therapeutics and methods to diagnose the disease earlier.  This project...

Two female doctors talking in the lab.

Apply for a Grant

Our funding programs support basic, translational and clinical research from academia and industry.

See Funding Opportunities
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.